Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Andexxa

Active ingredient: Coagulation Factor XA Recombinant Inactivated Zhzo

Andexxa is recorded in this directory with the active ingredient Coagulation Factor XA Recombinant Inactivated Zhzo. This page brings together catalogue strength, dosage-form and pack records so they can be checked against a prescription.

NEXT STEP

Choose the strength and pack

No ready-made options were found for this medicine. You can type the details in the form.

Continue to the form

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Andexxa used for?

Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) is a Factor Xa inhibitor reversal agent indicated for patients treated with rivaroxaban and apixaban, when rapid reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

It is available in lyophilized powder form in single-use vials of 200 mg or 100 mg of coagulation factor Xa (recombinant), inactivated-zhzo.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Andexxa identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordAndexxa
Active ingredientCoagulation Factor XA Recombinant Inactivated Zhzo
Dosage formCheck the pack record
Recorded options0
Directory areaHaematology

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

No ready-made option can be shown.

Do not guess a missing strength or pack; use the details on the prescription and medicine box.

OFFICIAL SOURCES

Check the Andexxa record at an official source.

Search for “Andexxa” or “Coagulation Factor XA Recombinant Inactivated Zhzo”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Andexxa.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Andexxa

01What is Andexxa?

This directory record associates the brand name Andexxa with the active ingredient Coagulation Factor XA Recombinant Inactivated Zhzo. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Andexxa strengths and packs are recorded?

No ready-made strength and pack option can currently be shown from the catalogue record. Do not guess missing details; use the prescription and medicine box.

03Who manufactures Andexxa?

No organisation name can currently be shown confidently from the catalogue record. Verify the manufacturer or marketing-authorisation holder on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Andexxa?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Andexxa, payment request, stock guarantee or binding offer.

06Can I buy Andexxa from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.